EUVIMEDEUVIMED entdecken
Crossref

Tailored multilayer nanoparticles against resistant P. aeruginosa by disrupting the thickened mucus, dense biofilm and hyperinflammation

Mao Xu, Shihui Yu, Pengyu Li, Yili Chen, Yujun Chen, Jieyi Pan, Xin Deng, Haiyan Hu

Journal of Controlled Release · 2025-02 · 378 · 588-604

DOI: 10.1016/j.jconrel.2024.12.040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025-02. Verfasst von Mao Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Biofilms, Pseudomonas aeruginosa, Nanoparticles, Anti-Bacterial Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Science and Technology Program Key Projects, Guangdong Provincial Key Laboratory of Construction Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic challenges of chronic pulmonary infections caused by multidrug-resistant Pseudomonas aeruginosa (MDRP. aeruginosa) biofilms due to significantly enhanced antibiotic resistance. This resistance is driven by reduced outer membrane permeability, biofilm barriers, and excessive secretion of virulence factors. Thickened mucus in the airways exacerbates the problem by impeding antibiotic penetration, providing a breeding ground for biofilms, consequently aggravating infection. Moreover, biofilms recruit numerous immune cells, resulting in chronic inflammation and lung tissue damage. In turn, damaged airway further facilitates bacterial colonization and elevated mucus production. To thoroughly disintegrate the stubborn triad of "thickened mucus & dense biofilm & excessive inflammation" and address drug resistance, tailored multilayer nanoparticles (NPVC/PBIP NPs) were developed. NPVC/PBIP NPs were engineered through self-assembly of vanillin-chitosan amphiphilic polymer loading polymyxin B-linoleic acid ion pairs in. Then polyaspartic acid and N-acetylcysteine-ε-poly-l-lysine were coated by layer-by-layer on the surface of vanillin-chitosan NPs via electrostatic interactions. As expected, the NAC units on NPVC/PBIP NPs effectively thinned human clinical sputum and porcine sputum, resulting in rapid sputum penetration followed by biofilm permeation. NPVC/PBIP NPs achieved over 99 % eradication of mature biofilms in vitro. Furthermore, they effectively inhibited virulence factors production and bacteria re-adhesion (biofilm reformation) while exhibiting superior anti-inflammatory and antioxidant activities. In a chronic pulmonary infection model, NPVC/PBIP NPs remarkably thinned airway mucus, reduced bacterial burden by 99.7 %, alleviated inflammatory cell infiltration, and minimized lung tissue damage. In summary, the NPVC/PBIP NPs represent a novel and promising strategy to manage MDRP. aeruginosa biofilms associated infections by disintegrating the stubborn triad of "thickened mucus & dense biofilm & excessive inflammation".

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsPseudomonas aeruginosaNanoparticlesAnti-Bacterial AgentsPseudomonas InfectionsAnimalsHumansMucusInflammationChitosanSwineDrug Resistance, Multiple, BacterialMiceSputum

Stichwörter der Autor:innen

Dense biofilmExcessive inflammationMDRP. aeruginosa biofilmsN-acetylcysteine-ε-poly-l-lysineTailored multilayer nanoparticlesThickened mucusVanillin-chitosan

Substanzen

Anti-Bacterial AgentsChitosan

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China. Electronic address: yushh8@mail.sysu.edu.cn.
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China; Department of Pharmacy, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha 410004,…
  • The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China.
  • Department of Biomedical Sciences, City University of Hong Kong, Kowloon Tong, Hong Kong, SAR 999077, China. Electronic address: xindeng@cityu.edu.hk.
  • School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China; State Key Laboratory of Anti-Infective Drug Discovery and Development, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guang…

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangzhou Science and Technology Program Key Projects
  • Guangdong Provincial Key Laboratory of Construction Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Xu, M., Yu, S., Li, P., Chen, Y., Chen, Y., Pan, J., Deng, X., & Hu, H. (2025). Tailored multilayer nanoparticles against resistant P. aeruginosa by disrupting the thickened mucus, dense biofilm and hyperinflammation. Journal of Controlled Release, 378, 588-604. https://doi.org/10.1016/j.jconrel.2024.12.040

Vancouver

Xu M, Yu S, Li P, Chen Y, Chen Y, Pan J, et al. Tailored multilayer nanoparticles against resistant P. aeruginosa by disrupting the thickened mucus, dense biofilm and hyperinflammation. Journal of Controlled Release. 2025;378:588-604. doi:10.1016/j.jconrel.2024.12.040

BibTeX
@article{Xu2025,
  author = {Xu, Mao and Yu, Shihui and Li, Pengyu and Chen, Yili and Chen, Yujun and Pan, Jieyi and Deng, Xin and Hu, Haiyan},
  title = {Tailored multilayer nanoparticles against resistant P. aeruginosa by disrupting the thickened mucus, dense biofilm and hyperinflammation},
  journal = {Journal of Controlled Release},
  year = {2025},
  volume = {378},
  pages = {588--604},
  doi = {10.1016/j.jconrel.2024.12.040}
}
Kostenlos starten →